Klaria Competitors and Similar CompaniesClear all

Klaria's competitors and similar companies include Exelixis and Halozyme Therapeutics.
Klaria
Klaria
Klaria Pharma Holding is a company that develops pharmaceuticals for migraine, cancer-related pain, and opioid overdoses.
Exelixis
Exelixis
Exelixis is an oncology company that develops cancer treatments.
Halozyme Therapeutics
Halozyme Therapeutics
Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
Founding Date
Founding Date
2014
Founding Date
1994
Founding Date
1998
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Uppsala, SE HQ
Locations
Alameda, US HQ
Locations
San Diego, US HQ
Employees
Employees
4
Employees
1,14712% decrease
Employees
373157% increase
Valuation ($)
Valuation ($)
7.8 m
Valuation ($)
8.2 b
Valuation ($)
6.4 b

Financial

Revenue (est.)
Revenue (est.)
kr9m (FY, 2025)
Revenue (est.)
$2.3b (FY, 2025)
Revenue (est.)
$1.4b (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
$83.7m (FY, 2025)
Cost of goods
$228.8m (FY, 2025)
Gross profit
Gross profit
kr9m (FY, 2025)
Gross profit
$2.2b (FY, 2025)
Gross profit
$1.2b (FY, 2025)
Net income
Net income
(kr38.9m) (FY, 2025)
Net income
$782.6m (FY, 2025)
Net income
$316.9m (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 3.3m
Total funding raised
N/A
Total funding raised
$ 171.9m
For sources of this data, please see the company profile

View Company Profiles

Exelixis
HQ
Alameda, US
Employees
1,147↓ 12% decrease

Exelixis is an oncology company that develops cancer treatments.

View company
Halozyme Therapeutics
HQ
San Diego, US
Employees
373

Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.

View company